Search arXiv⌕ Search
Home/Archive/arXiv

arXiv · 2601.21643

Computational investigation of single herbal drugs in Ayurveda for diabetes and obesity using knowledge graph and network pharmacology

Priyotosh Sil·Rahul Tiwari·Vasavi Garisetti·Shanmuga Priya Baskaran·Fenita Hephzibah Dhanaseelan·Smita Srivastava·Areejit Samal
View original source ↗Read source document ↗Export metadata ↓

Abstract

Metabolic diseases such as type 2 diabetes and obesity represent a rapidly escalating global health burden, yet current therapeutic strategies largely target isolated symptoms or single molecular pathways. To this end, we developed an integrated computational pipeline leveraging knowledge graph, pathway analysis and network pharmacology to elucidate the multi-target mechanisms of Ayurvedic Single Herbal Drugs (SHDs). SHDs associated with diabetes and obesity were curated from the Ayurvedic Pharmacopoeia of India, followed by phytochemical identification using IMPPAT database, yielding a shortlist of 11 SHDs and their 188 phytochemicals after drug-likeness and bioavailability filtering. Subsequently, molecular targets of the phytochemicals in SHDs, disease-associated genes and therapeutic targets of FDA-approved drugs, were curated via integration of data from several databases. Pathway enrichment analysis revealed significant functional overlap between SHD-associated and disease-associated pathways. All curated data were embedded into a Neo4j-based knowledge graph, enabling SHD-disease intersection analysis that prioritized key disease-relevant targets, including PTPN1, GLP1R, and DPP4. Also, the SHD-Target-FDA-approved drug profile elucidated the molecular and mechanistic aspects of the SHDs as a phytochemical cocktail, and is in alignment with the clinically studied synergistic FDA-approved drug combinations. Network pharmacology based protein-protein interaction analysis identified PPARG as another central regulator. Using a quantitative framework, we identified phytochemical pairs within SHDs, which were structurally dissimilar and target-wise distinct, yet acted on shared or different disease-associated pathways, indicating complementary and potentially synergistic interactions. Molecular docking analysis of two selected druggable targets identified putative lead phytochemicals.

Explore related subjects

q-bio.MNq-bio.SC

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Priyotosh Sil, Rahul Tiwari, Vasavi Garisetti, Shanmuga Priya Baskaran, Fenita Hephzibah Dhanaseelan, Smita Srivastava, Areejit Samal. 2026-01-29. Computational investigation of single herbal drugs in Ayurveda for diabetes and obesity using knowledge graph and network pharmacology. https://arxiv.org/abs/2601.21643

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Mapping disease-regulatory flux through eQTL-based causal gene networks: a complex-trait framework applied to coronary artery disease

A substantial proportion of inherited susceptibility to common diseases is mediated through tissue-specific regulatory variation. The omnigenic model hypothesizes that much of this risk arises from distant (trans) regulatory effects that are propagated via gene-regulatory networks (GRNs) from numerous regulatory genes onto a relatively small set of core genes. Two major challenges have hindered an empirical assessment of this model. First, transcriptome-wide association studies primarily assess gene expression that is regulated locally (in cis), and thus miss trans-acting effects. Second, trans regulation has so far been examined only in aggregate, without identifying which regulatory genes transmit disease-associated signals to which target genes. Here, we present a framework that decomposes each gene's disease association into a local cis component and a set of trans components attributable to its upstream regulators, propagated along a directed causal GRN. For each gene, we estimate sparse Bayesian expression models and we assess model performance using out-of-sample prediction. Propagating trans signals through the inferred network yields a disease-regulatory flux map: a directed, signed representation that quantifies the contribution of each regulator to the disease association of each target gene. Applying this framework to seven tissues relevant to coronary artery disease, we demonstrate how genetic variation flows through the GRN to affect disease risk. Outgoing regulatory influences from individual genes are directionally heterogeneous, whereas disease-associated genes tend to integrate convergent input from multiple regulators; these convergent targets are enriched for cardiovascular-related biological processes. Consequently, each gene's disease association can be reinterpreted as a detailed allocation of the disease signal among its contributing regulators.

q-bio.MN↗
arXiv2026

Local energetic coupling enhances the expressivity of chemical computation

Living systems compute with chemistry by mapping environmental signals onto specific internal chemical states. Despite recent advances in molecular programming, it remains unclear which physicochemical features control the computational expressivity of chemical systems. Here we inverse-design thermodynamically consistent chemical reaction networks whose steady-state response to an environmental input computes a target nonlinear function. Using implicit differentiation we train the free-energy landscape directly: standard chemical potentials, transition-state energies and thermodynamic drives. Increasingly large networks generated by elementary ligation and cleavage steps fit increasingly complex nonmonotonic polynomial functions, with expressivity scaling logarithmically with network size, predicted primarily by the number of reactions. Training individual energetic parameter classes reveals that internal thermodynamic drives, capable of breaking detailed balance, dominate trainability, with comparable performances achieved only by pairs of parameter classes. These results identify nonequilibrium drive as the most effective single resource for steady-state computational expressivity in chemical reaction networks.

q-bio.MN↗
arXiv2026

Orchestra: Corroboration-Based Regulatory Candidate Discovery via Composed Bioinformatics MCP Agents

Orchestra composes two independently built bioinformatics MCP servers -- RegNetAgents, which infers gene regulatory network topology from ARACNe networks, and CASCADE, which supplies four independent evidence sources (LINCS knockdown, DepMap essentiality, super-enhancer status, DoRothEA transcription-factor confidence) -- into one multi-agent workflow exposed via the Model Context Protocol. Its central architectural claim is that requiring RegNetAgents' topology evidence and CASCADE's experimental evidence to agree on a candidate regulator yields a more trustworthy candidate than either alone -- not previously tested directly, since RegNetAgents' own validation asked only whether its candidate lists beat chance. We test this on the TCGA tumor-acquired regulator tier (regulators in a gene's tumor ARACNe network but absent from the GREmLN population-averaged baseline), selecting candidates by ARACNe mutual-information (MI) edge weight. On RegNetAgents' published BRCA/COAD focal-gene panel plus matched negative controls, agreement among at least 2 of the 4 CASCADE sources predicts OncoKB cancer-gene status among focal genes (odds ratio 2.89, Benjamini-Hochberg-adjusted p=0.0166) but not among negative controls (p=0.0721); a single source is not diagnostic for either group. The pattern replicates and strengthens in a third cancer type, STAD, on a separately constructed panel (odds ratio 5.82), and against an independently curated ground truth (the Sanger COSMIC Cancer Gene Census). MI edge weight is the strongest single predictor overall (p=0.0003); a logistic-regression likelihood-ratio test confirms corroboration adds value beyond it in both panels (p=0.0234; p=0.0001). Every experiment invokes Orchestra's real agentic entry point.

q-bio.MN↗